DIA Europe – Updated
Vitafood – Home events – may 2019

Latest news

Expanded approval for Praluent in EU

Expanded approval for Praluent in EU

European regulators have approved a new indication for Regeneron and Sanofi’s Praluent (alirocumab) to reduce cardiovascular risk in adults with established atherosclerotic CV disease (ASCVD).
Roche’s MabThera approved in Europe for pemphigus vulgaris

Roche’s MabThera approved in Europe for pemphigus vulgaris

Roche’s MabThera (rituximab) has been approved in Europe for the treatment of adults with moderate-to-severe pemphigus vulgaris (PV). PV is a...
Iktos and Merck discovering new compounds with AI

Iktos and Merck discovering new compounds with AI

A new collaboration agreement will see Iktos use its generative modelling AI technology to facilitate the rapid and cost-effective discovery and design of promising...